Department of Ultrasound, Dingxi People's Hospital, Dingxi, Gansu Province, China.
Department of General Surgery, Dingxi People's Hospital, Dingxi, Gansu Province, China.
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820959355. doi: 10.1177/1533033820959355.
Ultrasound-targeted microbubble destruction (UTMD) has been found to be an effective method for delivering microRNAs (miRNAs, miRs). The current study is aimed at discovering the potential anti-cancer effects of UTMD-mediated miR-206 on HCC.
In our study, the expressions of miR-206 and peptidyl-prolyl isomerase B (PPIB) in HCC tissues and cells were detected by quantitative real-time polymerase chain reaction (qRT-PCR). PPIB expressions in HCC and adjacent normal tissues were analyzed by gene expression profiling interactive analysis (GEPIA). MiR-206 mimic and mimic control were transfected into HCC cells using UTMD. Potential binding sites between miR-206 and PPIB were predicted and confirmed by TargetScan and dual-luciferase reporter assay, respectively. Cell migration, invasion, and apoptosis were detected by wound healing assay, Transwell, and flow cytometry, respectively. The expressions of apoptosis-related proteins (Bax, Bcl-2), Epithelial-to-mesenchymal (EMT) markers (E-cadherin, N-cadherin and Snail) and PPIB were measured by Western blot.
MiR-206 expression was downregulated while PPIB expression was upregulated in HCC, and PPIB was recognized as a target gene of miR-206 in HCC tissues. UTMD-mediated miR-206 inhibited HCC cell migration and invasion while promoting apoptosis via regulating the expressions of proteins related to apoptosis, migration, and invasion by targeting PPIB.
Our results suggested that the delivery of UTMD-mediated miR-206 could be a potential therapeutic method for HCC treatment, given its effects on inhibiting cell migration and invasion and promoting cell apoptosis.
超声靶向微泡破坏(UTMD)已被发现是递送 microRNAs(miRNAs,miRs)的有效方法。本研究旨在发现 UTMD 介导的 miR-206 对 HCC 的潜在抗癌作用。
在我们的研究中,通过定量实时聚合酶链反应(qRT-PCR)检测 HCC 组织和细胞中 miR-206 和肽基脯氨酰顺反异构酶 B(PPIB)的表达。通过基因表达谱交互分析(GEPIA)分析 HCC 和相邻正常组织中的 PPIB 表达。使用 UTMD 将 miR-206 模拟物和模拟物对照转染入 HCC 细胞。通过 TargetScan 和双荧光素酶报告基因测定分别预测和验证 miR-206 和 PPIB 之间的潜在结合位点。通过划痕愈合试验、Transwell 和流式细胞术分别检测细胞迁移、侵袭和凋亡。通过 Western blot 测定凋亡相关蛋白(Bax、Bcl-2)、上皮-间充质(EMT)标志物(E-钙粘蛋白、N-钙粘蛋白和 Snail)和 PPIB 的表达。
miR-206 在 HCC 中表达下调,而 PPIB 表达上调,并且 PPIB 在 HCC 组织中被认为是 miR-206 的靶基因。UTMD 介导的 miR-206 通过靶向 PPIB 调节与凋亡、迁移和侵袭相关的蛋白表达,抑制 HCC 细胞迁移和侵袭,同时促进凋亡。
我们的结果表明,UTMD 介导的 miR-206 的递送可能是 HCC 治疗的一种潜在治疗方法,因为它可以抑制细胞迁移和侵袭并促进细胞凋亡。